BioSenic S.A.
BIOS.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €1,342 | €8,387 | €11,533 | €14,193 |
| - Cash | €391 | €117 | €1,846 | €9,510 |
| + Debt | €27,727 | €28,519 | €23,790 | €3,525 |
| Enterprise Value | €28,678 | €36,789 | €33,477 | €8,208 |
| Revenue | €0 | €543 | €296 | €312 |
| % Growth | -100% | 83.4% | -5.1% | – |
| Gross Profit | -€196 | €543 | €296 | €987 |
| % Margin | – | 100% | 100% | 316.3% |
| EBITDA | -€4,836 | -€6,796 | -€2,258 | -€864 |
| % Margin | – | -1,251.6% | -762.8% | -276.9% |
| Net Income | -€4,768 | -€28,778 | -€2,041 | -€984 |
| % Margin | – | -5,299.8% | -689.5% | -315.4% |
| EPS Diluted | -0.021 | -0.21 | -0.017 | -0.046 |
| % Growth | 90.2% | -1,135.3% | 63.2% | – |
| Operating Cash Flow | -€2,233 | -€3,470 | -€1,910 | -€12,784 |
| Capital Expenditures | €2,233 | €3,498 | -€5 | -€207 |
| Free Cash Flow | €0 | -€3,470 | -€1,915 | -€12,991 |